choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Exjade

Exjade Newsletter
  • After FDA exit, Peter Marks pops up at Lilly 08 Oct 2025 11:23 GMT

    … development of Novartis' Exjade (deferasirox), the first oral … 's Center for Drug Evaluation and Research, Patricia … join Pfizer as chief medical officer. Former Commissioner Robert … administration, while Scott Gottlieb, FDA Commissioner in Trump' …

  • Antengene Appoints Amily Zhang as its Chief Medical Officer 07 Dec 2022 06:02 GMT

    … obtained multiple Investigational New Drug (IND) approvals in … clinical development and medical affairs in the pharmaceutical industry, and … in the registration of Exjade® and Nexavar®, as … class therapeutics for the treatment of hematologic malignancies and …

  • Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients 07 Jun 2022 08:23 GMT

    … adhere well to prescribed drug treatment.47 Patients who … sessions with his doctor and specialist nurse … Therapeutics plc, and Agios Pharmaceuticals Ltd, outside the submitted … and accounting for medication adherence in clinical trials. Clin Pharmacol …

  • Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz 26 Oct 2021 06:57 GMT

    … global leader in generic pharmaceuticals and biosimilars. Its global … knee NIS793 Granted FDA orphan drug designation in combination … cancer Results from ongoing trials and other highlights … create transformative treatments in areas of great medical need. In …

  • Novartis Pharmaceuticals Agrees to Pay $678M to Settle Doctor-Bribe Claims 02 Jul 2020 15:30 GMT

    … sales of its Exjade and Myfortic drugs. Exjade reduces iron levels … doctors to choose the best treatment for their patients and increases drug … charitable foundations to pay Medicare patients’ co-pays in … is US v. Novartis Pharmaceutical Corp., 11-cv-0071, …

  • Novartis to pay $678 million to settle doctor-bribe claims 02 Jul 2020 08:45 GMT

    … set to go to trial last year before being … sales of its Exjade and Myfortic drugs. Exjade reduces iron levels … doctors to choose the best treatment for their patients and increases drug … three charitable foundations to pay Medicare patients’ co-pays in …

  • Immunomedics Gets Early FDA Approval - Path To Profitability Still Treacherous 28 Apr 2020 15:49 GMT

    … from the FDA for Trodelvy (sacituzumab govitecan) for the treatment of … 39;s Antibody Drug Conjugate (ADC) Trodelvy, The trial was for third … on reps who visited doctor';s offices in a … plan. Semerjian is an experienced biotech executive with a track record …

  • Bristol Myers/Acceleron's Reblozyl Label Expansion Gets FDA Nod 07 Apr 2020 08:47 GMT

    … aamt). The drug has been approved for the treatment of anemia … (“MAA”) to the European Medicines Agency (EMA). The MAA … oral iron chelating agents Exjade and Jadenu.Both Bristol … for outperformance. Our recent biotech recommendations have produced gains of …

  • Global Iron Metabolism Disorders Drugs Market worth US$ XX Billion by 2029 11 Jan 2020 20:07 GMT

    … copy of Iron Metabolism Disorders Drugs Market : https:// … : In 2013, Novartis drug Exjade first treatment got approved by FDA for chronic iron … , Cipla Ltd., ApoPharma Inc., Teva Pharmaceutical Industries Limited, Sun Pharma Industries …

Satisfied with the content?

Continue to create your account.